SEC Form 4 · accession 0000899243-18-022429
Adicet Bio, Inc. · ACET
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Jeffrey Chodakewitz
Director
Period of report
Aug 14, 2018
Accepted (ET)
Aug 15, 2018 · 8:25 am EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001720580
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F1 | $10.42 | Aug 14, 2018 | A | 28,828 | A | — | Aug 14, 2028 | Common Stock | 28,828 | 28,828 | D |
Explanation of responses
- F133% of the shares shall vest on August 14, 2019, with the remainder vesting ratably monthly thereafter.